• Neurontin
• Abuse
• Addiction
• Anger
• Anxiety
• Attorney
• Class Action
• Dangers
• Depression
• Drug
• Effects
• Information
• Lawsuit
• Litigation
• Overdose
• Pain
• Replacement
• Side Effects
• Suicide
• Uses
• Warnings
• Withdrawal

Find a Lawyer in Your State

Find a Lawyer by State Alaska Alabama Arizona Arkansas California Colorado Connecticut Delaware D.C. Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

Need Help?

• Birth Injury
• Digitek Lawyer
• Heparin Overdose
• Ortho Evra Lawyer
• Ortho Evra Side Effects
• Lavaquin
• Shoulder Pain Pump
• Nephrogenic Systemic Fibrosis
• Paxil Birth Defects
  

Submit your claim details for a free, no obligation case review

 

Get Started:

Find a Lawyer by State Alaska Alabama Arizona Arkansas California Colorado Connecticut Delaware D.C. Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

January 22nd, 2004

"Pfizer''s Profits Fall Following Personal Injury Claims and Government Investigation"

Pfizer''s profits are suffering, attributed to the $1.5 billion charge in personal injury claims from its diabetes drug Rezulin. The drug company is also under a government investigation due to the marketing practices of Neurontin epilepsy and pain medication. Some analysts were surprised at the effect Rezulin and Neurontin had on net income.